| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10217710 | Digestive and Liver Disease | 2018 | 4 Pages |
Abstract
Faecal HMGB1 is a valuable marker of intestinal inflammation and may have a role in complementing serology in the management of CD children. Future studies including larger patient cohorts and small bowel mucosa histology will be designed to assess the relationship between faecal HMGB1 levels and duodeno-jejunal histopathology.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Francesca Palone, Roberta Vitali, Chiara Maria Trovato, Monica Montuori, Anna Negroni, Saverio Mallardo, Laura Stronati,